Prostate-specific antigen velocity is not better than total prostate-specific antigen in predicting prostate biopsy diagnosis

Prostate-specific antigen velocity does not add predictive value for prostate biopsy diagnosis. The clinical significance of the prostate specific antigen test can be improved by separating Gleason 7 prostate cancers into a 3 + 4 and 4 + 3 group.